opc 15161 has been researched along with transforming growth factor beta in 1 studies
| Studies (opc 15161) | Trials (opc 15161) | Recent Studies (post-2010) (opc 15161) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kao, WW; Kawashima, Y; Kimura, M; Nakano, Y; Ohkawa, K; Ohnishi, Y; Ooshima, A; Saika, S; Yamanaka, O | 1 |
1 other study(ies) available for opc 15161 and transforming growth factor beta
| Article | Year |
|---|---|
OPC-15161 suppresses the proliferation of Tenon's capsule fibroblasts and the production of type I collagen and fibronectin stimulated by TGF-beta1 in vitro.
Topics: Adult; Cell Count; Cell Division; Cells, Cultured; Connective Tissue; DNA Replication; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Fibronectins; Humans; Laminin; Male; Middle Aged; Procollagen; Pyrazines; Tetrazolium Salts; Thiazoles; Transforming Growth Factor beta | 1998 |